{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:04:10Z","timestamp":1759334650514,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.jfo.2011.04.006","type":"journal-article","created":{"date-parts":[[2011,6,20]],"date-time":"2011-06-20T21:23:19Z","timestamp":1308604999000},"page":"502-507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Innovations th\u00e9rapeutiques dans les pathologies vasculaires et n\u00e9ovasculaires hors DMLA"],"prefix":"10.1016","volume":"34","author":[{"given":"C.","family":"Creuzot-Garcher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2011.04.006_bib0005","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/IAE.0b013e3181b1bb1a","article-title":"Anti-VEGF drugs as the 2009\u00a0first-line therapy for choroidal neovascularization in pathologic myopia","volume":"29","author":"Cohen","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2011.04.006_bib0010","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0161-6420(95)30849-4","article-title":"Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion","volume":"102","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2011.04.006_bib0015","doi-asserted-by":"crossref","unstructured":"McIntosh RL, Rogers SL, Lim L, Cheung N, Wang JJ, Mitchell P, et al. Natural history of central retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2010;117:1113\u201323\u00a0e15.","DOI":"10.1016\/j.ophtha.2010.01.060"},{"key":"10.1016\/j.jfo.2011.04.006_bib0020","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ophtha.2006.11.011","article-title":"Interventions for central retinal vein occlusion: an evidence-based systematic review","volume":"114","author":"Mohamed","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2011.04.006_bib0025","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.preteyeres.2008.09.003","article-title":"Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management","volume":"27","author":"Kaur","year":"2008","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jfo.2011.04.006_bib0030","doi-asserted-by":"crossref","unstructured":"Rogers SL, McIntosh RL, Lim L, Mitchell P, Cheung N, Kowalski JW, et al. Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2010;117:1094-101\u00a0e5.","DOI":"10.1016\/j.ophtha.2010.01.058"},{"key":"10.1016\/j.jfo.2011.04.006_bib0035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0002-9394(84)90316-7","article-title":"Argon laser photocoagulation for macular edema in branch vein occlusion","volume":"98","year":"1984","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2011.04.006_bib0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/02713680701851902","article-title":"Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities","volume":"33","author":"Rehak","year":"2008","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jfo.2011.04.006_bib0045","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/archopht.1995.01100040072030","article-title":"Laser-induced chorioretinal venous anastomosis for treatment of nonischemic central retinal vein occlusion","volume":"113","author":"McAllister","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2011.04.006_bib0050","doi-asserted-by":"crossref","unstructured":"McAllister IL, Gillies ME, Smithies LA, Rochtchina E, Harper CA, Daniell MD, et al. The Central Retinal Vein Bypass Study: a trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusion. Ophthalmology 2010;117:954\u201365.","DOI":"10.1016\/j.ophtha.2009.10.026"},{"key":"10.1016\/j.jfo.2011.04.006_bib0055","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archophthalmol.2009.234","volume":"127","author":"Ip","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2011.04.006_bib0060","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/archophthalmol.2009.233","volume":"127","author":"Scott","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2011.04.006_bib0065","doi-asserted-by":"crossref","unstructured":"Haller JA, Bandello F, Belfort R, Jr., Blumenkranz MS, Gillies M, Heier J, et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010;117:1134\u201346\u00a0e3.","DOI":"10.1016\/j.ophtha.2010.03.032"},{"key":"10.1016\/j.jfo.2011.04.006_bib0070","doi-asserted-by":"crossref","unstructured":"Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S, Saroj N, et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010;117:1124\u201333\u00a0e1.","DOI":"10.1016\/j.ophtha.2010.02.022"},{"key":"10.1016\/j.jfo.2011.04.006_bib0075","doi-asserted-by":"crossref","unstructured":"Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle AC, et al. Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010;117:1102\u201312\u00a0e1.","DOI":"10.1016\/j.ophtha.2010.02.021"},{"key":"10.1016\/j.jfo.2011.04.006_bib0080","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jfo.2009.10.002","article-title":"Retinal vein occlusion: anti-VEGF treatments","volume":"32","author":"Nghiem-Buffet","year":"2009","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2011.04.006_bib0085","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/archophthalmol.2009.226","article-title":"SCOREing in retinal venous occlusive disease","volume":"127","author":"Apte","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2011.04.006_bib0090","doi-asserted-by":"crossref","unstructured":"Bressler NM, Schachat AP. Management of macular edema from retinal vein occlusions: you can never have too many choices. Ophthalmology 2010;117:1061\u20133.","DOI":"10.1016\/j.ophtha.2010.03.037"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551211001707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551211001707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:02:14Z","timestamp":1759258934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551211001707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0181551211001707"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2011.04.006","relation":{},"ISSN":["0181-5512"],"issn-type":[{"type":"print","value":"0181-5512"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innovations th\u00e9rapeutiques dans les pathologies vasculaires et n\u00e9ovasculaires hors DMLA","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2011.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}